Routine laboratory measures of heparin anticoagulation for children on extracorporeal membrane oxygenation: Systematic review and meta-analysis

D. P. Padhya, G. J. Prutsky, M. E. Nemergut, G. S. Schears, Randall Flick, W. Farah, Zhen Wang, L. J. Prokop, Mohammad H Murad, M. Alsawas

Research output: Contribution to journalReview article

Abstract

Objective: Specific protocols for anticoagulation for children on ECMO vary across institutions, with most using a continuous infusion of unfractionated heparin. The goal of this study is to aid clinician's decision on the best measure of heparin anticoagulation test; which would be the one that correlates well with heparin activity and helps in predicting hemorrhagic and thrombotic complications. Data sources: A comprehensive search of MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, and Scopus was conducted from each database's inception to 07/13/2018. Study selection: Studies evaluating children (<18 years)treated with ECMO and evaluating ACT, aPTT, TEG and Anti-Xa in any language were included. Data extraction: Two reviewers selected and appraised studies independently, and abstracted data. Results: We included 19 studies (759 patients, mean age 19.8 months). Meta-analysis showed strong correlation between heparin dosing and anti-Xa. Additionally, there was not a strong correlation between laboratory tests and complications (hemorrhagic and thrombosis), or mortality. Conclusion: Based on current evidence, Anti-Xa is the only laboratory test that shows strong correlation with heparin infusion dose and seems like the most suitable test for monitoring of anticoagulation with heparin in children on ECMO.

Original languageEnglish (US)
Pages (from-to)132-139
Number of pages8
JournalThrombosis research
Volume179
DOIs
StatePublished - Jul 1 2019

Fingerprint

Extracorporeal Membrane Oxygenation
Heparin
Meta-Analysis
Databases
Decision Support Techniques
Information Storage and Retrieval
MEDLINE
Thrombosis
Language
Mortality

Keywords

  • Anticoagulation
  • Complications
  • Extracorporeal membrane oxygenation
  • Laboratory measures
  • Pediatrics

ASJC Scopus subject areas

  • Hematology

Cite this

Routine laboratory measures of heparin anticoagulation for children on extracorporeal membrane oxygenation : Systematic review and meta-analysis. / Padhya, D. P.; Prutsky, G. J.; Nemergut, M. E.; Schears, G. S.; Flick, Randall; Farah, W.; Wang, Zhen; Prokop, L. J.; Murad, Mohammad H; Alsawas, M.

In: Thrombosis research, Vol. 179, 01.07.2019, p. 132-139.

Research output: Contribution to journalReview article

Padhya, D. P. ; Prutsky, G. J. ; Nemergut, M. E. ; Schears, G. S. ; Flick, Randall ; Farah, W. ; Wang, Zhen ; Prokop, L. J. ; Murad, Mohammad H ; Alsawas, M. / Routine laboratory measures of heparin anticoagulation for children on extracorporeal membrane oxygenation : Systematic review and meta-analysis. In: Thrombosis research. 2019 ; Vol. 179. pp. 132-139.
@article{c9ef4c96d875487daca49e30036c39c4,
title = "Routine laboratory measures of heparin anticoagulation for children on extracorporeal membrane oxygenation: Systematic review and meta-analysis",
abstract = "Objective: Specific protocols for anticoagulation for children on ECMO vary across institutions, with most using a continuous infusion of unfractionated heparin. The goal of this study is to aid clinician's decision on the best measure of heparin anticoagulation test; which would be the one that correlates well with heparin activity and helps in predicting hemorrhagic and thrombotic complications. Data sources: A comprehensive search of MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, and Scopus was conducted from each database's inception to 07/13/2018. Study selection: Studies evaluating children (<18 years)treated with ECMO and evaluating ACT, aPTT, TEG and Anti-Xa in any language were included. Data extraction: Two reviewers selected and appraised studies independently, and abstracted data. Results: We included 19 studies (759 patients, mean age 19.8 months). Meta-analysis showed strong correlation between heparin dosing and anti-Xa. Additionally, there was not a strong correlation between laboratory tests and complications (hemorrhagic and thrombosis), or mortality. Conclusion: Based on current evidence, Anti-Xa is the only laboratory test that shows strong correlation with heparin infusion dose and seems like the most suitable test for monitoring of anticoagulation with heparin in children on ECMO.",
keywords = "Anticoagulation, Complications, Extracorporeal membrane oxygenation, Laboratory measures, Pediatrics",
author = "Padhya, {D. P.} and Prutsky, {G. J.} and Nemergut, {M. E.} and Schears, {G. S.} and Randall Flick and W. Farah and Zhen Wang and Prokop, {L. J.} and Murad, {Mohammad H} and M. Alsawas",
year = "2019",
month = "7",
day = "1",
doi = "10.1016/j.thromres.2019.05.006",
language = "English (US)",
volume = "179",
pages = "132--139",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Routine laboratory measures of heparin anticoagulation for children on extracorporeal membrane oxygenation

T2 - Systematic review and meta-analysis

AU - Padhya, D. P.

AU - Prutsky, G. J.

AU - Nemergut, M. E.

AU - Schears, G. S.

AU - Flick, Randall

AU - Farah, W.

AU - Wang, Zhen

AU - Prokop, L. J.

AU - Murad, Mohammad H

AU - Alsawas, M.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Objective: Specific protocols for anticoagulation for children on ECMO vary across institutions, with most using a continuous infusion of unfractionated heparin. The goal of this study is to aid clinician's decision on the best measure of heparin anticoagulation test; which would be the one that correlates well with heparin activity and helps in predicting hemorrhagic and thrombotic complications. Data sources: A comprehensive search of MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, and Scopus was conducted from each database's inception to 07/13/2018. Study selection: Studies evaluating children (<18 years)treated with ECMO and evaluating ACT, aPTT, TEG and Anti-Xa in any language were included. Data extraction: Two reviewers selected and appraised studies independently, and abstracted data. Results: We included 19 studies (759 patients, mean age 19.8 months). Meta-analysis showed strong correlation between heparin dosing and anti-Xa. Additionally, there was not a strong correlation between laboratory tests and complications (hemorrhagic and thrombosis), or mortality. Conclusion: Based on current evidence, Anti-Xa is the only laboratory test that shows strong correlation with heparin infusion dose and seems like the most suitable test for monitoring of anticoagulation with heparin in children on ECMO.

AB - Objective: Specific protocols for anticoagulation for children on ECMO vary across institutions, with most using a continuous infusion of unfractionated heparin. The goal of this study is to aid clinician's decision on the best measure of heparin anticoagulation test; which would be the one that correlates well with heparin activity and helps in predicting hemorrhagic and thrombotic complications. Data sources: A comprehensive search of MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, and Scopus was conducted from each database's inception to 07/13/2018. Study selection: Studies evaluating children (<18 years)treated with ECMO and evaluating ACT, aPTT, TEG and Anti-Xa in any language were included. Data extraction: Two reviewers selected and appraised studies independently, and abstracted data. Results: We included 19 studies (759 patients, mean age 19.8 months). Meta-analysis showed strong correlation between heparin dosing and anti-Xa. Additionally, there was not a strong correlation between laboratory tests and complications (hemorrhagic and thrombosis), or mortality. Conclusion: Based on current evidence, Anti-Xa is the only laboratory test that shows strong correlation with heparin infusion dose and seems like the most suitable test for monitoring of anticoagulation with heparin in children on ECMO.

KW - Anticoagulation

KW - Complications

KW - Extracorporeal membrane oxygenation

KW - Laboratory measures

KW - Pediatrics

UR - http://www.scopus.com/inward/record.url?scp=85066078924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066078924&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2019.05.006

DO - 10.1016/j.thromres.2019.05.006

M3 - Review article

C2 - 31132667

AN - SCOPUS:85066078924

VL - 179

SP - 132

EP - 139

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

ER -